1. Home
  2. EQIX vs SNY Comparison

EQIX vs SNY Comparison

Compare EQIX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equinix Inc. REIT

EQIX

Equinix Inc. REIT

HOLD

Current Price

$1,002.10

Market Cap

94.7B

Sector

Real Estate

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$47.86

Market Cap

107.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQIX
SNY
Founded
1998
1994
Country
United States
France
Employees
N/A
74846
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.7B
107.3B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
EQIX
SNY
Price
$1,002.10
$47.86
Analyst Decision
Strong Buy
Buy
Analyst Count
22
5
Target Price
$1,001.81
$58.00
AVG Volume (30 Days)
515.2K
3.2M
Earning Date
04-29-2026
04-23-2026
Dividend Yield
2.06%
3.34%
EPS Growth
61.88
N/A
EPS
13.76
N/A
Revenue
$5,998,545,000.00
N/A
Revenue This Year
$12.32
$3.86
Revenue Next Year
$8.85
$5.64
P/E Ratio
$72.66
$6.14
Revenue Growth
7.85
N/A
52 Week Low
$701.41
$43.32
52 Week High
$1,006.56
$55.73

Technical Indicators

Market Signals
Indicator
EQIX
SNY
Relative Strength Index (RSI) 69.74 62.50
Support Level $759.85 $47.30
Resistance Level N/A $48.97
Average True Range (ATR) 18.10 0.77
MACD -0.94 0.47
Stochastic Oscillator 88.40 90.85

Price Performance

Historical Comparison
EQIX
SNY

About EQIX Equinix Inc. REIT

Equinix is one of the leading providers of cloud- and carrier-neutral data centers, offering colocation and interconnection services to hyperscalers and businesses. Equinix operates 270 properties in 77 metropolitan areas across 36 countries, serving over 10,000 customers. About 70% of Equinix's revenue comes from renting physical space, which allows hyperscalers and other clients to store servers, data storage, and networking equipment. The other 30% of revenue is generated primarily through interconnection services (20%) and other managed services (10%).

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: